Dr. Reddys Laboratories is currently trading at Rs. 2572.15, up by 19.45 points or 0.76% from its previous closing of Rs. 2552.70 on the BSE. The... ...http://acml.accordfintech.com/News/NewsDetails.aspx?sec=4&subsec=38&Newsid=304338&id=1
Dr Reddy's Laboratories rose 0.98% to Rs 2577.70 at 11:04 IST on BSE after the firm said it has launched Fenofibrate Capsules, USP 43 mg and 130 mg... ...http://www.indiainfoline.com/Markets/News/Dr-Reddys-Lab-gains-after-launch-of-a-generic-medicine-in-US/5312250944
Observing that the government can impose stringent technical requirements to provide best possible medical devices for the purpose of public health... ...http://newsonair.nic.in/news.asp?cat=Business&id=BN1090
A Far Eastern 'cherry blossom shower' on Bangalore may not be far off, and not just because it now has a hospital named after Japan's favourite... ...http://www.thehindu.com/news/national/karnataka/karnataka-beckons-japanese-companies/article5926361.ece?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS_Syndication
Among the various warning letters that the US Food and Drug Administration (FDA) issued to companies found wanting in terms of meeting the... ...http://blogs.intoday.in/index.php?option=com_myblog&show=Usfda-indiancompany-datafudging-dataintegrity.html&blogs=9&contentid=63119
Miocon is pleased to introduce...